Investigation into the role of novel interferon lambdas in the treatment of viral disease, primarily hepatitis C
Interferon lambdas (IFNλs), termed IFN-λ1, IFN-λ2 and IFN-λ3, or IL-29, IL-28A and IL-28B are a recently identified family of cytokines with antiviral activity. IL-28A/B and IL-29 bind to a novel heterodimeric receptor complex formed between IL-28 receptor (IL-28R) and IL-10 receptor (IL-10R2). Type...
Main Author: | Lowe, Rhiannon May |
---|---|
Other Authors: | Thursz, Mark ; Morley, Peter |
Published: |
Imperial College London
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.568015 |
Similar Items
-
Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes
by: Nimisha Chaturvedi, et al.
Published: (2019-09-01) -
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
by: Qian Chen, et al.
Published: (2021-08-01) -
POLYMORPHIC VARIANTS OF THE GENE OF INTERFERON LAMBDA 3 AND FEATURES OF IMMUNE RESPONSE IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C
by: T. B. Sentsova, et al.
Published: (2017-09-01) -
The role of T-regulatory lymphocytes in the pathogenesis of chronic viral Hepatitis B and C
by: Rushbrook, Simon Matthew
Published: (2008) -
The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C
by: F. Bellanti, et al.
Published: (2012-01-01)